AVXL Earnings

Quarterly EPS
$-0.13
Q2 2024
$-0.14
Q3 2024
$-0.14
Q4 2024
$-0.14
Q1 2025
$-0.13
Q2 2025
$-0.16
Q3 2025
$-0.11
Q4 2025
$-0.06
Q1 2026
Latest RevenueN/A
Latest Net Income-5681000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q1 2026-$0.060-5681000+57.1%
Q4 2025-$0.110-9827000+21.4%
Q3 2025-$0.160-13243000-14.3%
Q2 2025-$0.130-11196000+0.0%
Q1 2025-$0.140-12111000-27.3%
Q4 2024-$0.140-11620000-16.7%
Q3 2024-$0.140-12214000+0.0%
Q2 2024-$0.130-10546000+23.5%
Q1 2024-$0.110-8622000
Q4 2023-$0.120-10146000
Q3 2023-$0.140-11280000
Q2 2023-$0.170-13107000
Anavex Life Sciences (AVXL) — Earnings